Ionis Pharmaceuticals | IONS - Current Liabilities



Ionis Pharmaceuticals reported $897.24M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Adcock Ingram Holdings ZAR 2.81B 279.84M Dec/2024
Agios Pharmaceuticals USD 70.41M 18.04M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 225.22M Jun/2025
Arrowhead Research USD 194.53M 26.01M Jun/2025
Astellas Pharma JPY 1.11T 46.33B Jun/2025
BioMarin Pharmaceutical USD 684.25M 56.03M Jun/2025
Celltrion KRW 3.4T 216.25B Mar/2025
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Divis Laboratories Ltd 14.52B 1.61B Mar/2025
Exelixis USD 336.11M 62.99M Jul/2025
Halozyme Therapeutics USD 134.28M 16.1M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
Kangmei Pharma CNY 5.75B 64.58M Jun/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Laboratorios Farma EUR 186.51M 29.86M Jun/2025
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 6.37M 3.17M Dec/2024
Moderna USD 1.57B 32M Jun/2025
Neuren Pharmaceuticals AUD 45.76M 36.79M Dec/2024
Neurocrine Biosciences USD 546.3M 23.4M Jun/2025
Novartis USD 31.71B 95M Jun/2025
OPKO Health USD 171.18M 21.92M Jun/2025
Organigram Holdings CAD 107.28M 38.32M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Pharma Mar EUR 87.78M 8.29M Jun/2025
PTC Therapeutics USD 627.81M 32.42M Jun/2025
Qiagen NV USD 1.13B 611.37M Jun/2025
Regeneron Pharmaceuticals USD 3.67B 100.4M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sarepta Therapeutics USD 919.95M 314.36M Jun/2025
Sartorius EUR 1.55B 72.7M Jun/2025
Sino Biopharmaceutical CNY 19.56B 2.39B Dec/2024
Tilray USD 278.52M 15.02M Nov/2024
Ultragenyx Pharmaceutical USD 293.24M 1.58M Jun/2025
Vertex Pharmaceuticals USD 4.14B 355.2M Jun/2025
Zz Pientze Pharmaceu 3.2B 878.89M Jun/2025